XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 464 participants.

Also called NCT02122718

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 464 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02122718
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02122718. Randomized; quadruple masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2021-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
Acronym
XILO-FIST
Condition
Ischaemic Stroke
Intervention (Drug)
Allopurinol
Intervention (Drug)
Placebo
Lead sponsor
NHS Greater Glasgow and Clyde (class: other)
Collaborator
University of Glasgow (class: other)

Record details

Record id
cardio:ct-nct02122718
Content hash
32618e8ad6d6190dea5cfb1f74b129c7d26e4faf878fe416d993b23f990062eb